Positron Corp (POSC)

$2.18 -0.14 (-6.03%)
Market Cap 71.61M
Revenue (ttm) 590,000.00
Net Income (ttm) -2.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -405.08%
Debt to Equity Ratio 0.00
Volume 20,700
Avg Vol 89,966
Day's Range N/A - N/A
Shares Out 32.85M
Stochastic %K 13%
Beta 0.70
Analysts Strong Buy
Price Target $0.04

Company Profile

Positron Corporation develops, manufactures, and sells cardiac positron emission tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, bil...

Industry: Medical Devices
Sector: Healthcare
Phone: 317 576 0183
Address:
3784 Commerce Court, Suite 100, North Tonawanda, United States
prevclose
prevclose Feb. 12 at 8:19 PM
$POSC the former CEO of Sun Microsystems owns this and is pumping it. Thats why it went ip couple days ago. He will be interviewed by Joe Kernan of CNBC tomorrow.
1 · Reply
Stockmesg
Stockmesg Feb. 11 at 8:54 PM
$POSC This company is NOT Positron AI. Positron AI is not a public company! This company sells PET-CT and PET-CT 64 scanners for medical use. Due your due diligence. It will be worth much more than $2/share by the end of 2026.
1 · Reply
evel2022
evel2022 Feb. 10 at 7:31 PM
$POSC cnbc got ya! will be a few years before investible.
0 · Reply
StMichaelTwits
StMichaelTwits Feb. 9 at 5:59 PM
$POSC Big financier and for this company was talking about it on Squawkbox CNBC Smaller big boy A1 company. Could be a nice long term play.😉
1 · Reply
osamabinrussell
osamabinrussell Feb. 5 at 5:13 PM
$POSC some news here would start to fly things off highkey
0 · Reply
Stockmesg
Stockmesg Jan. 29 at 10:28 PM
$POSC Nice gain today. Maybe people are becoming more aware of the fantastic opportunity ahead!!
0 · Reply
SkylineCCG
SkylineCCG Nov. 17 at 4:11 PM
Skyline highlights our client Positron Corporation $POSC following the Company’s announcement that it has officially become a reporting company with the U.S. Securities and Exchange Commission. Positron filed its Form 10 registration statement, initiating full reporting under the Securities Exchange Act of 1934. This marks an important milestone that enhances financial transparency, strengthens governance, and supports Positron’s long-term strategy as it continues preparing for an uplisting to a senior exchange. 🔗 Learn more about this announcement here: https://www.globenewswire.com/news-release/2025/11/17/3189247/0/en/Positron-Corporation-Announces-Its-Transition-to-a-Reporting-SEC-Company.html #SkylineCCG #InvestorRelations #Positron #POSC #MolecularImaging #MedicalImaging #HealthcareTechnology Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
Stockmesg
Stockmesg Nov. 15 at 1:20 AM
$POSC fully reporting company now. Can apply for up list in 60 days!
0 · Reply
SkylineCCG
SkylineCCG Oct. 2 at 3:26 PM
Positron Corporation (OTC: $POSC), a leader in molecular imaging technology specializing in PET and PET-CT systems and clinical services, has entered into an industry partnership agreement with MedAxiom — the cardiovascular community’s premier source for organizational performance solutions. Through this partnership, Positron gains access to MedAxiom’s nationwide network of physicians, clinicians, and administrators, further advancing the adoption of PET imaging in cardiovascular medicine. The collaboration provides valuable clinical insights, market intelligence, and opportunities to engage with leaders driving innovation in nuclear cardiology. This partnership underscores Positron’s commitment to improving patient care through broader PET-CT utilization and meaningful collaboration with the cardiovascular community. 🔗 Read more here: https://www.globenewswire.com/news-release/2025/10/02/3160432/0/en/Positron-Corporation-Enters-Industry-Partnership-Agreement-with-MedAxiom.html Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Sep. 29 at 3:21 PM
Congratulations to our client, Positron Corporation (OTC: $POSC), on being recognized with the Innovation Award in the PET-CT Imaging category at the 2025 Medical Device Network Excellence Awards. This honor highlights Positron’s substantial impact on advancing hybrid imaging technology. With their latest PET-CT systems, Positron is driving progress in affordability, workflow, and clinical applications—making hybrid imaging more accessible, efficient, and versatile for healthcare providers worldwide. The Medical Device Network Excellence Awards, powered by GlobalData, celebrate the most significant innovations shaping the future of the global medical device industry. Positron’s recognition is a testament to their dedication to improving patient care through transformative technology. 🔗 Read more here: https://www.medicaldevice-network.com/excellence-awards/featured-company/positron-pet-ct-64-medical-imaging-excellence/ #MedicalDevices #PETCT #HybridImaging #HealthcareTechnology #SkylineCCG Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
Latest News on POSC
No data available.
prevclose
prevclose Feb. 12 at 8:19 PM
$POSC the former CEO of Sun Microsystems owns this and is pumping it. Thats why it went ip couple days ago. He will be interviewed by Joe Kernan of CNBC tomorrow.
1 · Reply
Stockmesg
Stockmesg Feb. 11 at 8:54 PM
$POSC This company is NOT Positron AI. Positron AI is not a public company! This company sells PET-CT and PET-CT 64 scanners for medical use. Due your due diligence. It will be worth much more than $2/share by the end of 2026.
1 · Reply
evel2022
evel2022 Feb. 10 at 7:31 PM
$POSC cnbc got ya! will be a few years before investible.
0 · Reply
StMichaelTwits
StMichaelTwits Feb. 9 at 5:59 PM
$POSC Big financier and for this company was talking about it on Squawkbox CNBC Smaller big boy A1 company. Could be a nice long term play.😉
1 · Reply
osamabinrussell
osamabinrussell Feb. 5 at 5:13 PM
$POSC some news here would start to fly things off highkey
0 · Reply
Stockmesg
Stockmesg Jan. 29 at 10:28 PM
$POSC Nice gain today. Maybe people are becoming more aware of the fantastic opportunity ahead!!
0 · Reply
SkylineCCG
SkylineCCG Nov. 17 at 4:11 PM
Skyline highlights our client Positron Corporation $POSC following the Company’s announcement that it has officially become a reporting company with the U.S. Securities and Exchange Commission. Positron filed its Form 10 registration statement, initiating full reporting under the Securities Exchange Act of 1934. This marks an important milestone that enhances financial transparency, strengthens governance, and supports Positron’s long-term strategy as it continues preparing for an uplisting to a senior exchange. 🔗 Learn more about this announcement here: https://www.globenewswire.com/news-release/2025/11/17/3189247/0/en/Positron-Corporation-Announces-Its-Transition-to-a-Reporting-SEC-Company.html #SkylineCCG #InvestorRelations #Positron #POSC #MolecularImaging #MedicalImaging #HealthcareTechnology Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
Stockmesg
Stockmesg Nov. 15 at 1:20 AM
$POSC fully reporting company now. Can apply for up list in 60 days!
0 · Reply
SkylineCCG
SkylineCCG Oct. 2 at 3:26 PM
Positron Corporation (OTC: $POSC), a leader in molecular imaging technology specializing in PET and PET-CT systems and clinical services, has entered into an industry partnership agreement with MedAxiom — the cardiovascular community’s premier source for organizational performance solutions. Through this partnership, Positron gains access to MedAxiom’s nationwide network of physicians, clinicians, and administrators, further advancing the adoption of PET imaging in cardiovascular medicine. The collaboration provides valuable clinical insights, market intelligence, and opportunities to engage with leaders driving innovation in nuclear cardiology. This partnership underscores Positron’s commitment to improving patient care through broader PET-CT utilization and meaningful collaboration with the cardiovascular community. 🔗 Read more here: https://www.globenewswire.com/news-release/2025/10/02/3160432/0/en/Positron-Corporation-Enters-Industry-Partnership-Agreement-with-MedAxiom.html Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Sep. 29 at 3:21 PM
Congratulations to our client, Positron Corporation (OTC: $POSC), on being recognized with the Innovation Award in the PET-CT Imaging category at the 2025 Medical Device Network Excellence Awards. This honor highlights Positron’s substantial impact on advancing hybrid imaging technology. With their latest PET-CT systems, Positron is driving progress in affordability, workflow, and clinical applications—making hybrid imaging more accessible, efficient, and versatile for healthcare providers worldwide. The Medical Device Network Excellence Awards, powered by GlobalData, celebrate the most significant innovations shaping the future of the global medical device industry. Positron’s recognition is a testament to their dedication to improving patient care through transformative technology. 🔗 Read more here: https://www.medicaldevice-network.com/excellence-awards/featured-company/positron-pet-ct-64-medical-imaging-excellence/ #MedicalDevices #PETCT #HybridImaging #HealthcareTechnology #SkylineCCG Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Sep. 24 at 4:18 PM
Our client, Positron Corporation (OTC: $POSC), is aligned with the latest industry direction as the American Society of Nuclear Cardiology (ASNC) emphasizes AI integration, expanded PET adoption, and new clinical applications in nuclear cardiology under incoming President Jamieson M. Bourque, MD, MHS. With advancements such as F-18 flurpiridaz and other emerging tracers, cardiovascular PET stands at a critical inflection point—offering broader access, innovative clinical uses, and improved patient outcomes. Positron continues to advance PET imaging technology, supporting the growth and future of nuclear cardiology. 🔗 Watch the video here: https://cardiovascularbusiness.com/topics/cardiac-imaging/nuclear-cardiology/incoming-asnc-president-making-ais-integration-nuclear-cardiology-top-priority?utm_source=newsletter&utm_medium=cvb_news #NuclearCardiology #CardiacPET #AI #MedicalImaging #HealthcareInnovation #SkylineCCG Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Aug. 22 at 2:04 PM
Skyline client, Positron Corporation (OTC: $POSC), has announced a major milestone with the establishment of its new corporate headquarters in the Buffalo-Niagara Falls region. The expanded facility will serve as the hub for corporate operations, a product showroom, and a testing center—supporting accelerated growth and customer engagement for Positron’s PET-CT imaging solutions. In addition, Positron’s Board of Directors has approved the Company’s redomiciling to Delaware, strengthening its corporate governance structure as it prepares to file a Form 10 registration with the SEC to become a fully reporting public company. 🔗 Read more here: https://www.globenewswire.com/news-release/2025/08/22/3137845/0/en/Positron-Corporation-Announces-New-Corporate-Headquarters-and-Strategic-Redomiciling-to-Delaware.html #Positron #InvestorRelations #CorporateGrowth #HealthcareInnovation #MedicalImaging #PublicCompanies Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Aug. 13 at 2:42 PM
🩺 Expanding Access to Advanced Cardiac Imaging Skyline client Positron Corporation (OTC: POSC) has secured a multi-unit sale of four PET-CT 64-slice scanners to a nationally recognized nuclear cardiology group specializing in advanced cardiovascular diagnostics and interventional care. Positron’s next-generation PET-CT systems are designed to deliver: 🩺High-resolution anatomic and functional imaging for cardiac and oncology applications 🩺A 72 cm wide-bore gantry for improved patient comfort 🩺High-sensitivity detectors that reduce radiation exposure 🩺A compact, lightweight design for versatile clinical integration This order highlights the growing demand for imaging solutions that optimize clinical outcomes, operational efficiency, and patient experience — reinforcing Positron’s position as a leader in molecular imaging technology. 📄 Read the full press release: https://www.globenewswire.com/news-release/2025/08/13/3132660/0/en/Positron-Corporation-Secures-Multi-Unit-Sale-of-PET-CT-Scanners-to-Leading-Cardiology-Group.html Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG May. 29 at 3:15 PM
Positron Corporation (OTC: $POSC) Expands Its Imaging Footprint Positron Corporation continues to gain traction in the molecular imaging space with the recent sale of its NeuSight PET-CT 64-slice scanner to a leading nuclear cardiologist focused on cardiovascular diagnostics and interventional care. The NeuSight PET-CT system is engineered for precision and performance—designed with a compact footprint, 72 cm gantry for patient comfort, and high-sensitivity imaging that reduces radiation exposure for both patients and staff. As healthcare providers seek smarter, space-conscious solutions, Positron’s platform offers a powerful edge for nuclear cardiology and molecular imaging environments nationwide. #MedicalImaging #MolecularImaging #CardiacPET #HealthcareTech #PETCTScanner #NuclearCardiology #SkylineClients #Positron #InvestorRelations Skyline is paid by $POSC for IR services. Disclaimer 17(b): https://skylineccg.com/disclosures/
0 · Reply
RunZeke
RunZeke May. 29 at 2:29 PM
$POSC https://www.positron.com/press-release?webmasterId=130005&storyId=6320363803024431
0 · Reply
PenkeInvesting
PenkeInvesting May. 17 at 4:51 AM
I found you a Three Black Crows Candle Pattern on the daily chart of Positron Corp. $POSC #Positron #ThreeBlackCrows #PINK
1 · Reply
SkylineCCG
SkylineCCG Apr. 14 at 4:37 PM
Positron Corporation (OTC: $POSC) has announced an agreement to sell four of its PET-CT scanners to a respected leader in cardiovascular diagnostics and treatment. As a molecular imaging medical device company specializing in PET and PET-CT imaging systems, Positron continues to strengthen its position in the cardiac imaging market by delivering advanced technology designed to improve diagnostic precision, workflow efficiency, and patient outcomes. This milestone highlights the increasing demand for cardiac PET imaging and our client's ability to meet the clinical and operational needs of healthcare providers nationwide. Check out the full press release here: https://www.globenewswire.com/news-release/2025/04/14/3061028/0/en/Positron-Corporation-Secures-Agreement-to-Sell-Four-PET-CT-Scanners.html #SkylineCCG #Positron #MolecularImaging #CardiacImaging #PETCT #HealthcareInnovation #MedicalDevices #ImagingSolutions #Cardiology #DiagnosticImaging Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Mar. 31 at 8:56 PM
Positron Corporation (OTC: $POSC) has secured $8 million in capital to fast-track growth and expand its footprint in the PET-CT imaging market. This equity-based investment fuels Positron’s momentum as a leading force in molecular imaging, powering initiatives across sales, marketing, product development, and global market expansion. It also lays the groundwork for a return to SEC filings and a future uplisting to a senior exchange. Congratulations to our client, read the full release here: https://www.globenewswire.com/news-release/2025/03/31/3052732/0/en/Positron-Corporation-Secures-8-Million-in-Capital-to-Accelerate-Growth-and-Market-Expansion.html #MolecularImaging #Cardiology #PETSCAN #MedTech #PETCT #InvestorNews #SkylineCCG #CapitalMarkets #MedTech #Investors Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
SkylineCCG
SkylineCCG Feb. 28 at 2:26 PM
Our client, Positron Corporation (OTC: $POSC) is revolutionizing cardiac imaging with the NeuSight™ PET-CT. The NeuSight™ PET-CT is designed to optimize imaging needs with advanced capabilities at an exceptional cost, bringing unmatched value to cardiac PET-CT imaging including: 🧠 Intelligent Software 📸 Exceptional Image Quality 🔬 Precision Craftsmanship As the demand for cutting-edge nuclear cardiology solutions grows, Positron is at the forefront, seamlessly integrating innovation and efficiency to enhance patient care and diagnostic accuracy. 🔗 Discover how NeuSight™ PET-CT is shaping the future of nuclear cardiology: https://www.positron.com/ #Positron #NeuSightPETCT #NuclearCardiology #PETCT #ImagingInnovation #SkylineCCG Skyline is paid by $POSC for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
0 · Reply
RealAvidTrader
RealAvidTrader Feb. 12 at 5:52 PM
🤷‍♂️I TOLD YOU THIS STOCK WAS A GUARANTEED DOUBLE🤷‍♂️ DO NOT FADE ME! $POSC $PRTT $EBFI https://youtu.be/f-h8WR5dBDI
1 · Reply
RealAvidTrader
RealAvidTrader Feb. 11 at 10:29 PM
$POSC HOPE YOU LISTENED This Penny Stock is a GUARANTEED Double!! https://youtu.be/Yx6wZNz95dM
0 · Reply
Stockmesg
Stockmesg Feb. 11 at 7:04 PM
$POSC 2.25 is next resistance
1 · Reply